SV Atlas
← All founders
David van Dijk

David van Dijk

Yale Professor | CEO, CellType (YC W26) | AI + Drug Discovery

Co-founderCellType logoCellType· Winter 2026🇺🇸 New Haven, Connecticut, United States
in LinkedIn𝕏 @david_van_dijk
2026Co-founder· CellType (YC W26)
Founder · since 2026
Company
CellType (YC W26)
Role
Co-Founder & CEO
current
Stage
—
no public source
Raised
—
no public source
Based
—
Founder / co-founder — the company's markEmployee / research role
Source: LinkedIn work history
Profile coverage5 of 7 · missing posts, contact
CellType logo
CellType

The agentic drug company. We simulate human biology.

Winter 2026

Experience

Career

  • CellType (YC W26) logo

    CellType (YC W26)

    Co-founder

    Co-Founder & CEO · 2026 – Present

    2026
  • Yale University logo

    Yale University

    Associate Professor · 2025 – Present

    2025
  • Yale University logo

    Yale University

    Assistant Professor · 2019 – 2025

    2019
  • Weizmann Institute of Science logo

    Weizmann Institute of Science

    Postdoctoral Researcher · 2013 – 2015

    2013

Bio

Co-Founder & CEO of CellType (W26). Yale Professor, 11,000+ citations. Built biological foundation models with Google. Building the agentic drug company.